Concept DHA is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by U.s. Pharmaceutical Corporation. The primary component is Ascorbic Acid; Biotin; Calcium Pantothenate; Cupric Sulfate; Cyanocobalamin; Ferrous Fumarate; Folic Acid; Iron; Magnesium Sulfate, Unspecified Form; Niacin; Omega-3-acid Ethyl Esters; Pyridoxine Hydrochloride; Riboflavin; Thiamine Mononitrate; Zinc Sulfate, Unspecified Form.
| Product ID | 52747-621_5cae5cdf-a82b-444c-9145-bc1166889d28 |
| NDC | 52747-621 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Concept DHA |
| Generic Name | Vitamin- Mineral Omega-3 Supplement |
| Dosage Form | Capsule, Liquid Filled |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-06-24 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | U.S. Pharmaceutical Corporation |
| Substance Name | ASCORBIC ACID; BIOTIN; CALCIUM PANTOTHENATE; CUPRIC SULFATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; IRON; MAGNESIUM SULFATE, UNSPECIFIED FORM; NIACIN; OMEGA-3-ACID ETHYL ESTERS; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE; ZINC SULFATE, UNSPECIFIED FORM |
| Active Ingredient Strength | 25 mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes | Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Fatty Acids, Omega-3 [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Omega-3 Fatty Acid [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2009-06-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-06-24 |
| Inactivation Date | 2019-10-21 |
| Ingredient | Strength |
|---|---|
| FERROUS FUMARATE | 53.5 mg/1 |
| SPL SET ID: | bd2051f7-b887-46f6-8d4a-b099fcd08629 |
| Manufacturer | |
| UNII |